COVID-19 UPDATE: Global Nicotine Addiction Treatment Market to Show Tremendous Growth by 2027 | Leading Players-Hager Biosciences, LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences, Inc

Global Nicotine Addiction Treatment Market By Type (Combustible Tobacco and Smokeless Tobacco), Treatment Type (Nicotine Replacement Therapy and Psychological Therapy), Drugs (Approved-Drugs, Off-label Drugs and Others), Product Type (Patch, Gum, Pills, Lozenge, Spray and Others),  Route of Administration(Oral, Inhalation and Injectable), Drug Delivery System(Transdermal Drug Delivery System, Buccal Drug Delivery System and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Global Nicotine Addiction Treatment Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global nicotine addiction treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Analysis: Global Nicotine Addiction Treatment Market

Global nicotine addiction treatment market is rising gradually with a healthy CAGR in the forecast period of 2019-2026. Government policies and initiatives to offer a fund to many research institute and pharmaceuticals companies for developing novel therapy and increase dependency of tobacco products are the key factors for market growth

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nicotine-addiction-treatment-market&pm

Key Market Players:

Few of the major competitors currently working in the global nicotine addiction treatment market are Hager Biosciences, LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences, Inc, Cerecor, Inc, Astraea Therapeutics LLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Pfizer Inc, Novartis AG, Sanofi, Dr. Reddy’s Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Mylan N.V. , Axsome Therapeutics, Inc. and others.

Market Definition: Global Nicotine Addiction Treatment Market

Nicotine is a stimulant drug and potent parasympathomimetic alkaloid found in the tobacco plant. Tobacco products contain nicotine is highly addictive causing craving for more of it. Nicotine addiction causes serious disease and death. Exposure of nicotine in adolescence can disrupt the brain development such as mood disorders. Nicotine replacement therapy is Over the Counter medication is most commonly used for smoking cessation. It reduces the withdrawal feelings by giving you a small controlled dose of nicotine and hence reduces the urge for smoke.

According to the statistics published in Alcohol and Drug Foundation, it is estimated up to 37.7% of people aged 14 years and above have used tobacco in the Australia. These growing cases of nicotine consumptions and high demand of novel therapies are the key drivers for market growth.

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nicotine-addiction-treatment-market&pm

Market Drivers

High prevalence of tobacco products consumptions acts as a market driver
Vulnerable adult population as adults are at high risk for nicotine addiction also drives the market growth
Increase in government initiatives and polices can also act as a market driver
Rapid adoption of newer formulations and novel dosage forms can boost the market growth

Market Restraints

Limited success of existing smoking cessation methods is also hampering the market growth
Preference of non-pharmacology therapies over pharmacology therapies can hinder the market growth
Patent expiry of major drugs and introduction of generic drugs of branded version is expected to restrict the growth of this market

Segmentation: Global Nicotine Addiction Treatment Market

By Type

Combustible Tobacco
Smokeless Tobacco

By Treatment Type

Nicotine Replacement Therapy
Psychological Therapy

By Drugs

Approved-Drugs
Nicotine
Varenicline
Bupropion Hydrochloride
Off-label Drugs
Clonidine
Topiramate
Naltrexone
Nortriptyline
Others

By Product Type

Patch
Gum
Pills
Lozenge
Spray
Others

By Route of Administration

Oral
Inhalation
Injectable

By Drug Delivery System

Transdermal Drug Delivery System
Buccal Drug Delivery System
Others

By End-Users

Hospitals
Homecare
Specialty Clinics
Others

Key Developments in the Market:

In June 2018, Omeros Corporation received approval from regulatory authority and ethics committee to initiate phase I clinical trial for its lead candidate PDE7, phosphodiesterase inhibitor for the treatment of all addictions including nicotine addiction and compulsive disorders. If successful, it will represent an immense and urgent unmet need for the treatment of nicotine addiction
In December 2017, Axsome Therapeutics, Inc entered into research collaboration with Duke University to develop AXS-05, a novel, oral, fixed-dose combination of dextromethorphan and bupropion. Under the deal terms, Duke University will be responsible for conducting preclinical research. This strategic alliance significantly contributes in solving the problem of tobacco addiction worldwide

For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nicotine-addiction-treatment-market&PM

Reasons to Purchase this Report

Current and future of global nicotine addiction treatment market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. 

This release was published on openPR.